Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the Fund was up 1.7% in USD terms and 1.1% in AUD terms but down 2.4% in EUR terms due to a strengthening currency. In addition, please check the fund’s top five holdings to know its best picks in 2025.
In its first-quarter 2025 investor letter, Conventum – Alluvium Global Fund highlighted stocks such as HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. he one-month return of HCA Healthcare, Inc. (NYSE:HCA) was -3.52%, and its shares gained 9.34% of their value over the last 52 weeks. On June 17, 2025, HCA Healthcare, Inc. (NYSE:HCA) stock closed at $372.45 per share, with a market capitalization of $89.602 billion.
Conventum – Alluvium Global Fund stated the following regarding HCA Healthcare, Inc. (NYSE:HCA) in its Q1 2025 investor letter:
“HCA Healthcare, Inc. (NYSE:HCA), the hospital and ambulatory site owner/operator, (up 15.4%) released its full year results. Management provided 2025 guidance of revenue up 5.2% and EPS up 13.4% – a little above our estimate of its maintainable earnings. We suspect the concerns over possible regulatory changes (which we wrote about here) have been put on the back burner whilst the market digests the tariff implications. We ended the quarter with a 7.9% position, which, given its current price and our view of its value, we are reasonably comfortable with.”
A team of healthcare professionals in lab coats and masks meeting at a hospital ward.
HCA Healthcare, Inc. (NYSE:HCA) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 74 hedge fund portfolios held HCA Healthcare, Inc. (NYSE:HCA) at the end of the first quarter, which was 81 in the previous quarter. While we acknowledge the potential of HCA Healthcare, Inc. (NYSE:HCA) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered HCA Healthcare, Inc. (NYSE:HCA) and shared the list of best inexpensive stocks to buy. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of HCA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
